TMVR system developer InnovHeart named Jason Bottiglieri as its new CEO. Bottiglieri brings over 22 years of experience to the role, including 18 years in the interventional cardiovascular market.
He previously served as the CEO of Infraredx, a start-up that developed a novel intravascular imaging system for detecting lipid core plaque.
He was a founding U.S. sales leader in Invatec, which was acquired by Medtronic and turned into its peripheral vascular business unit. He has also served in leadership roles for Johnson & Johnson, Cordis and Spectranetics.